Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Tessera: engineering mobile genetic elements for gene insertion

Flagship newco Tessera uses mobile genetic elements to make gene insertions

Lauren Martz, Senior Editor
July 7, 2020 10:57 PM UTC

Tessera Therapeutics, the latest company to emerge from Flagship Pioneering, is developing a suite of gene editing tools based on mobile genetic elements that have the potential to create a broader range of genomic alterations than CRISPR.

The company came out of stealth on Tuesday with over $50 million in funding from Flagship, two years of research supporting its Gene Writing platform and a team of genetic engineering veterans. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Flagship Pioneering Inc.